Lakefront Biotherapeutics (LKFT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 535,352 | 680,383 | 1,035,250 | 1,407,552 | 2,642,298 |
| Marketable Securities | 3,778,152 | 3,713,100 | 3,678,071 | 3,803,246 | 2,922,031 |
| Receivables | 70,122 | 54,766 | 68,170 | 88,116 | 151,631 |
| Inventories | 55,762 | 25,694 | 28,742 | 20,646 | 24,335 |
| Other current assets | 24,557 | 20,584 | 13,991 | 11,675 | 11,765 |
| TOTAL | $4,463,945 | $4,494,526 | $4,824,223 | $5,331,235 | $5,752,060 |
| Non-Current Assets | |||||
| PPE Net | 162,520 | 151,477 | 158,423 | 163,725 | 162,690 |
| Intangibles | 227,754 | 215,024 | 219,900 | 66,379 | 71,108 |
| Other Non-Current Assets | 133,894 | 146,843 | 161,115 | 162,234 | 158,170 |
| TOTAL | $524,167 | $513,344 | $539,438 | $392,338 | $391,968 |
| Total Assets | $4,988,112 | $5,007,869 | $5,363,659 | $5,723,574 | $6,144,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 156,644 | 155,859 | 171,066 | 151,124 | 162,579 |
| Other current liabilities | N/A | N/A | N/A | 437 | 241 |
| TOTAL | $550,546 | $536,039 | $586,082 | $631,682 | $670,195 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 385,229 | 372,325 | 406,605 | 469,219 | 496,744 |
| Other Non-Current Liabilities | 28,814 | 1,762,109 | 1,960,748 | 24,061 | 45,536 |
| TOTAL | $1,776,145 | $1,762,109 | $1,960,748 | $2,121,889 | $2,346,472 |
| Total Liabilities | $2,326,691 | $2,298,147 | $2,546,830 | $2,753,570 | $3,016,666 |
| Shareholders' Equity | |||||
| Common Shares | 309,341 | 295,719 | 311,838 | 328,347 | 345,554 |
| Retained earnings | -523,312 | -329,259 | -390,967 | -410,859 | -434,440 |
| Other shareholders' equity | -6,792 | -11,992 | -12,563 | -13,375 | -14,078 |
| TOTAL | $2,661,421 | $2,709,721 | $2,816,829 | $2,970,002 | $3,127,362 |
| Total Liabilities And Equity | $4,988,112 | $5,007,868 | $5,363,659 | $5,723,572 | $6,144,028 |